Literature DB >> 27718061

Society of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.

Caryn E Peterson1, J Andrew Dykens2, Noel T Brewer3, Joanna Buscemi2, Karriem Watson2, DeLawnia Comer-Hagans4, Zo Ramamonjiarivelo4, Marian Fitzgibbon2.   

Abstract

Human papillomavirus (HPV) vaccine coverage remains low in the USA. The Society for Behavioral Medicine (SBM) supports the goals outlined by Healthy People 2020, the President's Cancer Panel, and the National Vaccine Advisory Committee to increase vaccination coverage among both males and females. SBM makes the following recommendations in support of efforts to reduce structural and other barriers to HPV vaccination services in order to increase rates of series completion. We encourage legislators and other policymakers to improve administration authority, insurance coverage, and reimbursement rates to healthcare providers who make the HPV vaccine available to adolescents; provide instrumental support to fund the development of school curricula on HPV vaccination; and increase public awareness that HPV vaccination can prevent cancer. We urge healthcare providers and healthcare systems to increase the strength, quality, and consistency of HPV vaccination recommendations for all eligible patients; to treat HPV vaccination as a routine preventive service; employ culturally appropriate communication strategies in clinical settings to educate eligible patients, parents, and guardians about the importance, effectiveness, and safety of HPV vaccination; and to strengthen and better coordinate the use of electronic medical records and immunization information systems.

Entities:  

Keywords:  Cervical cancer; HPV vaccination; HPV-related cancers; Increasing HPV vaccine coverage; US policy; Uptake

Mesh:

Substances:

Year:  2016        PMID: 27718061      PMCID: PMC5110504          DOI: 10.1007/s13142-016-0441-5

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  26 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-05-28       Impact factor: 17.586

3.  Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction.

Authors:  Jessica A Kahn; Darron R Brown; Lili Ding; Lea E Widdice; Marcia L Shew; Susan Glynn; David I Bernstein
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

4.  Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013.

Authors:  Judy Ng; Faye Ye; Lindsey Roth; Katherine Sobel; Sepheen Byron; Mary Barton; Megan Lindley; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-10-30       Impact factor: 17.586

Review 5.  Factors associated with HPV vaccine uptake in teenage girls: a systematic review.

Authors:  Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher
Journal:  Vaccine       Date:  2012-04-03       Impact factor: 3.641

6.  Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.

Authors:  Z Berkowitz; M Malone; J Rodriguez; M Saraiya
Journal:  Prev Med       Date:  2015-10-24       Impact factor: 4.018

7.  Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.

Authors:  Hugo De Vuyst; Gary M Clifford; Maria Claudia Nascimento; Margaret M Madeleine; Silvia Franceschi
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

8.  Provider communication and HPV vaccination: The impact of recommendation quality.

Authors:  Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer
Journal:  Vaccine       Date:  2016-01-24       Impact factor: 3.641

9.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors:  L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

View more
  4 in total

1.  A 6-year update of the health policy and advocacy priorities of the Society of Behavioral Medicine.

Authors:  Joanna Buscemi; Gary G Bennett; Sherri Sheinfeld Gorin; Sherry L Pagoto; James F Sallis; Dawn K Wilson; Marian L Fitzgibbon
Journal:  Transl Behav Med       Date:  2017-12       Impact factor: 3.046

Review 2.  Application of theoretical frameworks on human papillomavirus vaccine interventions in the United States: systematic review and meta-analysis.

Authors:  Cesia Cotache-Condor; Matthew Peterson; Matthew Asare
Journal:  Cancer Causes Control       Date:  2021-10-27       Impact factor: 2.506

3.  Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.

Authors:  Chung-Yuan Lee; Chih-Jen Tseng; Chi-Chang Chang; Meng-Chih Lee; Shun-Fa Yang
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 4.  Internal and External Validity of Social Media and Mobile Technology-Driven HPV Vaccination Interventions: Systematic Review Using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework.

Authors:  Matthew Asare; Braden Popelsky; Emmanuel Akowuah; Beth A Lanning; Jane R Montealegre
Journal:  Vaccines (Basel)       Date:  2021-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.